Technical Analysis for ABVC - ABVC Biopharma, Inc.

Grade Last Price % Change Price Change
C 0.66 -4.49% -0.03
ABVC closed down 4.49 percent on Friday, November 1, 2024, on 1.15 times normal volume. It was able to find support at its 50 day moving average.
Earnings due: Nov 13
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Flat

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Calm After Storm Range Contraction -4.49%
Upper Bollinger Band Walk Strength -4.49%
Wide Bands Range Expansion -4.49%
Overbought Stochastic Strength -4.49%
Gapped Down Weakness -4.49%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ABVC Biopharma, Inc. Description

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pancreatic Cancer Depression Major Depressive Disorder Myelodysplastic Syndrome Attention Deficit Hyperactivity Disorder Treatment Of Pancreatic Cancer Triple Negative Breast Cancer

Is ABVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.22
52 Week Low 0.4053
Average Volume 147,283
200-Day Moving Average 0.94
50-Day Moving Average 0.64
20-Day Moving Average 0.60
10-Day Moving Average 0.66
Average True Range 0.07
RSI (14) 52.83
ADX 29.11
+DI 24.82
-DI 14.43
Chandelier Exit (Long, 3 ATRs) 0.56
Chandelier Exit (Short, 3 ATRs) 0.62
Upper Bollinger Bands 0.77
Lower Bollinger Band 0.43
Percent B (%b) 0.69
BandWidth 56.42
MACD Line 0.02
MACD Signal Line 0.00
MACD Histogram 0.0165
Fundamentals Value
Market Cap 5.22 Million
Num Shares 7.91 Million
EPS -3.57
Price-to-Earnings (P/E) Ratio -0.18
Price-to-Sales 14.34
Price-to-Book 1.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.79
Resistance 3 (R3) 0.79 0.76 0.77
Resistance 2 (R2) 0.76 0.73 0.76 0.76
Resistance 1 (R1) 0.71 0.71 0.69 0.70 0.75
Pivot Point 0.67 0.67 0.67 0.67 0.67
Support 1 (S1) 0.62 0.64 0.61 0.62 0.57
Support 2 (S2) 0.59 0.62 0.59 0.56
Support 3 (S3) 0.54 0.59 0.55
Support 4 (S4) 0.53